Leaderboards/Colorectal Cancer Screening and Detection

Colorectal Cancer Screening and Detection

Last updated July 15, 2026

Rising Stars

Fresh ink, massive impact

Researchers

1
Angela N. Giaquinto
American Cancer Society
2
Tyler B. Kratzer
American Cancer Society
3
Andrew M. D. Wolf
University of Virginia
4
Krishnan Sathishkumar
National Centre for Disease Informatics and Research
5
Gloria D. Coronado
University of Arizona
6
Krzysztof Budzyń
Górnośląskie Centrum Medyczne
7
Sophia J. Wagner
Brigham and Women's Hospital
8
Gianmarco Piccinno
University of Trento
9
Rebecca L Siegel
American Cancer Society
10
Abraham Gihawi
University of East Anglia

Papers

1
Breast cancer statistics 2024
CA A Cancer Journal for Clinicians|2024
645 cit.
2
Lung cancer statistics, 2023
Cancer|2024
457 cit.
3
Endoscopist deskilling risk after exposure to artificial intelligence in colonoscopy: a multicentre, observational study
˜The œLancet. Gastroenterology & hepatology|2025
154 cit.
4
Publication in Nature Medicine (2025) [78 citations, W4410974032]
Nature Medicine|2025
78 cit.
5
Breast cancer survival in India across 11 geographic areas under the National Cancer Registry Programme
Cancer|2024
60 cit.
6
The landscape of microbial associations in human cancer
Science Translational Medicine|2025
14 cit.
7
Geographic Disparities in Oral Cancer Survival From 10 Population-Based Cancer Registries in India
JAMA Network Open|2025
9 cit.
8
Lobular breast cancer statistics, 2025
Cancer|2025
9 cit.
9
Publication in Polskie Archiwum Medycyny Wewnętrznej (2024) [3 citations, W4391144613]
Polskie Archiwum Medycyny Wewnętrznej|2024
3 cit.
10
Publication in CA A Cancer Journal for Clinicians (2026) [3 citations, W7162515953]
CA A Cancer Journal for Clinicians|2026
3 cit.

Emerging Leaders

Drafting the new consensus

Researchers

1
Xiaogang Liu
Tongji University
2
Jakob Nikolas Kather
Heidelberg University
3
Melina Arnold
Roche (Switzerland)
4
Ndiya Ogba
National Comprehensive Cancer Network
5
Miranda M Fidler-Benaoudia
Alberta Health Services
6
Masayuki Tsuneki
Yale University
7
Folasade P. May
University of California, Los Angeles
8
Peter S. Liang
New York University
9
Anas M. Saad
The Barbara Ann Karmanos Cancer Institute
10
Krzysztof J. Geras
Circulatory Technology (United States)

Papers

1
Current and future burden of breast cancer: Global statistics for 2020 and 2040
The Breast|2022
3.2k cit.
2
Global Burden of Cutaneous Melanoma in 2020 and Projections to 2040
JAMA Dermatology|2022
1.4k cit.
3
Global patterns and trends in breast cancer incidence and mortality across 185 countries
Nature Medicine|2025
821 cit.
4
Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study
Cancer Cell|2023
247 cit.
5
Swarm learning for decentralized artificial intelligence in cancer histopathology
Nature Medicine|2022
209 cit.
6
Benchmarking weakly-supervised deep learning pipelines for whole slide classification in computational pathology
Medical Image Analysis|2022
173 cit.
7
In-context learning enables multimodal large language models to classify cancer pathology images
Nature Communications|2024
132 cit.
8
Improving breast cancer diagnostics with deep learning for MRI
Science Translational Medicine|2022
126 cit.
9
Adversarial attacks and adversarial robustness in computational pathology
Nature Communications|2022
110 cit.
10
Development and validation of an autonomous artificial intelligence agent for clinical decision-making in oncology
Nature Cancer|2025
108 cit.

Current Senior Leaders

Wrote the book, still writing it

Researchers

1
Ahmedin Jemal
American Cancer Society
2
Freddie Bray
Centre international de recherche sur le cancer
3
David Forman
University of Leeds
4
Jie He
First Affiliated Hospital of Jinan University
5
Elizabeth Ward
American Cancer Society
6
Douglas K. Rex
Indiana University School of Medicine
7
Lynn M. Matrisian
Pancreatic Cancer Action Network
8
Sudhir Srivastava
National Cancer Institute
9
Evelien Dekker
Academic Medical Center
10
Hermann Brenner
Universidad de Granada

Papers

1
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
CA A Cancer Journal for Clinicians|2021
112.5k cit.
2
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
CA A Cancer Journal for Clinicians|2018
87.7k cit.
3
Global cancer statistics
CA A Cancer Journal for Clinicians|2011
55k cit.
4
Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
International Journal of Cancer|2014
29k cit.
5
Global cancer statistics, 2012
CA A Cancer Journal for Clinicians|2015
27.4k cit.
6
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
CA A Cancer Journal for Clinicians|2024
23.1k cit.
7
Cancer statistics, 2020
CA A Cancer Journal for Clinicians|2020
21.4k cit.
8
Cancer statistics, 2019
CA A Cancer Journal for Clinicians|2019
21k cit.
9
Cancer statistics, 2022
CA A Cancer Journal for Clinicians|2022
18.2k cit.
10
Cancer statistics in China, 2015
CA A Cancer Journal for Clinicians|2016
18k cit.

Reagents for Colorectal Cancer Screening and Detection

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 65

Bim (C34C5) Rabbit Monoclonal Antibody (Alexa Fluor® 488 Conjugate)

#94805$465
View Evidence →
RocheEvidence 75

VENTANA® anti-BRAF V600E (VE1) Mouse Monoclonal Primary Antibody

#760-5095 (also 08033706001)
View Evidence →
Cell Signaling TechnologyEvidence 65

BAF Antibody

#62935$317
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 63

Phospho-GSK-3 alpha/beta (Ser21/9) (37F11) Rabbit Monoclonal Antibody

Cited in 5 papers
#9327$179,968
View Evidence →
Cell Signaling TechnologyEvidence 64

Neurofilament-H (E7Z7G) Rabbit Monoclonal Antibody (BSA and Azide Free)

Cited in 5 papers
#40459$865
View Evidence →
Cell Signaling TechnologyEvidence 67

MGMT Antibody

#2739$317
View Evidence →